Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
DIGITAL HOLDINGS,INC. Drives business DX with data-driven advertising, CRM consulting, and AI integration.	Japan	2389
DIGITALIFT Inc. Digital marketing firm providing programmatic ad operations and strategic consulting services.	Japan	9244
D.L.S.I. HR and recruitment services for temp, fixed-term, and permanent roles across industries.	France	ALDLS
Dogwood Therapeutics, Inc. Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.	United States of America	DWTX
Doric Nimrod Air Three Limited Investment firm leasing four Airbus A380s to Emirates for shareholder returns.	Guernsey	DNA3
DP Aircraft I Limited Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.	Guernsey	DPA
DreamCIS INC. A CRO providing clinical research services for pharma, biotech, and medical device industries.	South Korea	223250
DT&CRO CO., Ltd. A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.	South Korea	383930
DUSKIN CO.,LTD. Franchises cleaning rentals and services for homes and businesses, and operates food chains.	Japan	4665
D.Western Therapeutics Institute, Inc. Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.	Japan	4576